Thus, the worse prognosis in NSCLC individuals is consistent with the idea that ALOX15B-derived 15(S)-HETE plays a protective role in the course of lung cancer either by activating PPARγ or by downregulating the expression of pro-angiogenic genes. The gene discussed is ALOX15B; the disease is non-small cell lung carcinoma.